English | Español

Astellas Pharma Us, Inc.
Carol Ostrow | Dec 3, 2017

Astellas will present AML findings at American Society of Hematology conference
Carrie Bradon | Dec 1, 2017

Astellas study shows women with overactive bladder symptoms use unconventional methods
Carrie Bradon | Nov 25, 2017

Astellas Oncology names C3 Prize winners
Marian Johns | Nov 19, 2017

Astellas receives perfect score on Corporate Equality Index for fourth consecutive year
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug
Marian Johns | Oct 19, 2017

Astellas Pharma, Seattle Genetics begin clinical trial for bladder cancer treatment
Robert Hadley | Jul 7, 2017

Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

Trending
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+ Pharmaceuticals
Patient Daily | Sep 22, 2025

Nurses United for Healthcare Integrity says hospitals abuse 340B drug pricing program